Table 2.
Oligonucleotide primers used in this study.
| Primers | Sequence 5′-3′ (Forward/Reverse) | Resource |
|---|---|---|
| QRT-PCR | ||
| 16s | 5′- AGCAACGCGAAGAACCTTAC-3′/5′- ATTTGACGTCATCCCCACCT-3′ | Sangon Biotech |
| ace | 5′- GGCGACTCAACGTTTGAC -3′/5′- TCCAGCCAAATCGCCTAC -3′ | Sangon Biotech |
| gelE | 5′- GGAACAGACTGCCGGTTTAG -3′/5′- TTCTGGATTAGATGCACCCG -3′ | Sangon Biotech |
| walR | 5′ -CATGGTCTCAAAACGGGGTG -3′/5′-AATAACCAACCCCACGACGA-3′ | Sangon Biotech |
| walK | 5′- CGCGTGTATGTGAATGTCCA -3′/5′- GCTTCGTGATTGATCGTGCA -3′ | Sangon Biotech |
| epaA | 5′- GCCTATGATGCACCAGGAGA -3′/5′- CAACCATTCCACCAGCCAAA -3′ | Sangon Biotech |
| QRT-PCR for ASwalR | ||
| PCR1 | 5′-ATGGTGACTGCCAAAGATTCT-3′ | First strand cDNA synthesis |
| AS2 | 5′- CGGCTTCTTTCGCATTGGTT -3′ | QRT-PCR analysis |